Genetically engineered phage harbouring the lethal catabolite gene activator protein gene with an inducer-independent promoter for biocontrol of Escherichia coli

FEMS Microbiology Letters

Volumn 296, Issue 1, 2009, Pages 67-71

  Moradpour, Zahra ^a   Sepehrizadeh, Zargham ^a   Rahbarizadeh, Fatemeh ^b   Ghasemian, Abdollah ^a   Yazdi, Mojtaba Tabatabaei ^a   Shahverdi, Ahmad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Antibacterial agent; Filamentous bacteriophage; Killing gene; Lethal catabolite gene activator protein; Phage therapy

Indexed keywords

CYCLIC AMP BINDING PROTEIN;

ARTICLE; BACTERIAL STRAIN; BACTERIOPHAGE; BACTERIUM PILUS; BIOLOGICAL PEST CONTROL; CONTROLLED STUDY; ESCHERICHIA COLI; GENETIC ENGINEERING; KLEBSIELLA PNEUMONIAE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROMOTER REGION; SALMONELLA PARATYPHI C; SHIGELLA DYSENTERIAE; TRANSGENIC ORGANISM;

AMINO ACID SUBSTITUTION; ANIMALS; BACTERIOPHAGE M13; CATTLE; COLONY COUNT, MICROBIAL; CULTURE MEDIA; CYCLIC AMP RECEPTOR PROTEIN; ESCHERICHIA COLI O157; MICROBIAL VIABILITY; MILK; MUTANT PROTEINS; PEST CONTROL, BIOLOGICAL; PROMOTER REGIONS, GENETIC;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; FILAMENTOUS BACTERIOPHAGE; LURIA;

EID: 67149123645     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2009.01620.x     Document Type: Article

References (24)

1. Alisky J, Iczkowski K, Rapoport A Troitsky N (1998) Bacteriophages show promise as antimicrobial agents. J Infect 36 : 5 15. (Pubitemid 128645619)
2. Damasko C, Konietzny A, Kaspar H, Appel B, Dersch P Strauch E (2005) Studies of the efficacy of enterocoliticin, a phage-tail like bacteriocin, as antimicrobial agent against Yersinia enterocolitica serotype O3 in a cell culture system and in mice. J Vet Med B 52 : 171 179. (Pubitemid 40995845)
3. Gruskin AB Shulman ST (2000) Antibiotic treatment of E. coli O157:H7 increases risk of hemolytic-uremic syndrome. AAP Grand Rounds 4 : 1 2.
4. Hagens S Blasi U (2003) Genetically modified filamentous phage as bactericidal agents: a pilot study. Lett Appl Microbiol 37 : 318 323. (Pubitemid 37186625)
5. Hanlon GW (2007) Bacteriophages: an appraisal of their role in the treatment of bacterial infections. Int J Antimicrob Agents 30 : 118 128. (Pubitemid 46977193)
6. Kasman LM, Kasman A, Westwater C, Dolan J, Schmidt MG Norris JS (2002) Overcoming the phage replication threshold: a mathematical model with implications for phage therapy. J Virol 76 : 5557 5564. (Pubitemid 34517906)
7. Krylov VN (2001) Phagotherapy in terms of bacteriophage genetics: hopes, perspectives, safety, limitations. Genetika 37 : 869 887. (Pubitemid 33772109)
8. Levin BR Bull JJ (2004) Population and evolutionary dynamics of phage therapy. Nat Rev Microbiol 2 : 166 173. (Pubitemid 39490070)
9. Lopata M, Schlieper D, von Wilcken-Bergmann B Muller-Hill B (1997) A lethal mutant of the catabolite gene activator protein CAP of Escherichia coli. Biol Chem 378 : 1153 1162. (Pubitemid 27474661)
10. Matsuzaki S, Rashel M, Uchiyama J et al 2005) Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases. J Infect Chemother 11 : 211 219. (Pubitemid 41570015)
11. Molbak K, Mead PS Griffin PM (2002) Antimicrobial therapy in patients with Escherichia coli O157:H7 infection. JAMA 288 : 1014 1016. (Pubitemid 34920469)
12. O'Flynn G, Ross RP, Fitzgerald GF Coffey A (2004) Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157:H7. Appl Environ Microb 70 : 3417 3424. (Pubitemid 38745886)
13. Sambrook J Russell DW (2001) Molecular Cloning: A Laboratory Manual, 3rd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
14. Schlieper D, Sobek H, Schmidt M, Wilcken-Bergmann B Müller-Hill B (1999) Positive selection vector based on the CAPS gene, PCAPS vector and its use. Patent No. 5891687, 4-6-1999.
15. Shahverdi AR, Fakhimi A, Zarrini G, Dehghan G Iranshahi M (2007a) Galbanic acid from Ferula szowitsiana enhanced the antibacterial activity of penicillin g and cephalexin against Staphylococcus aureus. Biol Pharm Bull 30 : 1805 1807. (Pubitemid 47403261)
16. Shahverdi AR, Monsef-Esfahani HR, Tavasoli F, Zaheri A Mirjani R (2007b) Trans-cinnamaldehyde from Cinnamomum zeylanicum bark essential oil reduces the clindamycin resistance of Clostridium difficile in vitro. J Food Sci 72 : S55 S58.
17. Skurnik M Strauch E (2006) Phage therapy: facts and fiction. Int J Med Microbiol 296 : 5 14. (Pubitemid 43089713)
18. Slopek S, Durlakowa I, Weber-Dabrowska B, Kucharewicz-Krukowska A, Dabrowski M Bisikiewicz R (1983) Results of bacteriophage treatment of suppurative bacterial infections. II. Detailed evaluation of the results. Arch Immunol Ther Exp (Warsz) 31 : 293 327.
19. Sulakvelidze A (2005) Phage therapy: an attractive option for dealing with antibiotic-resistant bacterial infections. Drug Discov Today 10 : 807 809. (Pubitemid 40824730)
20. Sulakvelidze A, Alavidze Z Morris JG Jr. (2001) Bacteriophage therapy. Antimicrob Agents Ch 45 : 649 659. (Pubitemid 32182003)
21. Tanji Y, Shimada T, Fukudomi H, Miyanaga K, Nakai Y Unno H (2005) Therapeutic use of phage cocktail for controlling Escherichia coli O157:H7 in gastrointestinal tract of mice. J Biosci Bioeng 100 : 280 287. (Pubitemid 41755292)
22. Viveiros M Amaral L (2001) Enhancement of antibiotic activity against poly-drug resistant Mycobacterium tuberculosis by phenothiazines. Int J Antimicrob Agents 17 : 225 228. (Pubitemid 32229901)
23. Westwater C, Kasman LM, Schofield DA, Werner PA, Dolan JW, Schmidt MG Norris JS (2003) Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infections. Antimicrob Agents Ch 47 : 1301 1307. (Pubitemid 36368589)
24. Yu SL, Ding HC, Seah JN, Wu KM, Chang YC, Chang KSS, Tam MF Syu WJ (1998) Characterization of a phage specific to hemorrhagic Escherichia coli O157: H7 and disclosure of variations in host outer membrane protein OmpC. J Biomed Sci 5 : 370 382. (Pubitemid 28467789)